These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 21538549)
1. Characterization of in vivo pharmacological properties and sensitivity to endogenous serotonin of [11C] P943: a positron emission tomography study in Papio anubis. Ridler K; Plisson C; Rabiner EA; Gunn RN; Easwaramoorthy B; Abi-Dargham A; Laruelle M; Slifstein M Synapse; 2011 Nov; 65(11):1119-27. PubMed ID: 21538549 [TBL] [Abstract][Full Text] [Related]
2. Assessing the sensitivity of [¹¹C]p943, a novel 5-HT1B radioligand, to endogenous serotonin release. Cosgrove KP; Kloczynski T; Nabulsi N; Weinzimmer D; Lin SF; Staley JK; Bhagwagar Z; Carson RE Synapse; 2011 Oct; 65(10):1113-7. PubMed ID: 21484884 [TBL] [Abstract][Full Text] [Related]
3. High-resolution imaging of brain 5-HT 1B receptors in the rhesus monkey using [11C]P943. Nabulsi N; Huang Y; Weinzimmer D; Ropchan J; Frost JJ; McCarthy T; Carson RE; Ding YS Nucl Med Biol; 2010 Feb; 37(2):205-14. PubMed ID: 20152720 [TBL] [Abstract][Full Text] [Related]
8. In vivo serotonin-sensitive binding of [11C]CUMI-101: a serotonin 1A receptor agonist positron emission tomography radiotracer. Milak MS; Severance AJ; Prabhakaran J; Kumar JS; Majo VJ; Ogden RT; Mann JJ; Parsey RV J Cereb Blood Flow Metab; 2011 Jan; 31(1):243-9. PubMed ID: 20571518 [TBL] [Abstract][Full Text] [Related]
9. Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943. Saricicek A; Chen J; Planeta B; Ruf B; Subramanyam K; Maloney K; Matuskey D; Labaree D; Deserno L; Neumeister A; Krystal JH; Gallezot JD; Huang Y; Carson RE; Bhagwagar Z Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):468-77. PubMed ID: 25427881 [TBL] [Abstract][Full Text] [Related]
10. Inverse changes in raphe and cortical 5-HT Baldassarri SR; Park E; Finnema SJ; Planeta B; Nabulsi N; Najafzadeh S; Ropchan J; Huang Y; Hannestad J; Maloney K; Bhagwagar Z; Carson RE Synapse; 2020 Oct; 74(10):e22159. PubMed ID: 32324935 [TBL] [Abstract][Full Text] [Related]
11. Kinetic modeling of the serotonin 5-HT(1B) receptor radioligand [(11)C]P943 in humans. Gallezot JD; Nabulsi N; Neumeister A; Planeta-Wilson B; Williams WA; Singhal T; Kim S; Maguire RP; McCarthy T; Frost JJ; Huang Y; Ding YS; Carson RE J Cereb Blood Flow Metab; 2010 Jan; 30(1):196-210. PubMed ID: 19773803 [TBL] [Abstract][Full Text] [Related]
12. The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. Gaster LM; Blaney FE; Davies S; Duckworth DM; Ham P; Jenkins S; Jennings AJ; Joiner GF; King FD; Mulholland KR; Wyman PA; Hagan JJ; Hatcher J; Jones BJ; Middlemiss DN; Price GW; Riley G; Roberts C; Routledge C; Selkirk J; Slade PD J Med Chem; 1998 Apr; 41(8):1218-35. PubMed ID: 9548813 [TBL] [Abstract][Full Text] [Related]
13. [ Lindberg A; Nag S; Schou M; Takano A; Matsumoto J; Amini N; Elmore CS; Farde L; Pike VW; Halldin C Nucl Med Biol; 2017 Nov; 54():34-40. PubMed ID: 28950161 [TBL] [Abstract][Full Text] [Related]
14. Effects of tryptophan depletion on the binding of [11C]-DASB to the serotonin transporter in baboons: response to acute serotonin deficiency. Milak MS; Ogden RT; Vinocur DN; Van Heertum RL; Cooper TB; Mann JJ; Parsey RV Biol Psychiatry; 2005 Jan; 57(1):102-6. PubMed ID: 15607307 [TBL] [Abstract][Full Text] [Related]
15. A PET study with [11C]AZ10419369 to determine brain 5-HT1B receptor occupancy of zolmitriptan in healthy male volunteers. Varnäs K; Jučaite A; McCarthy DJ; Stenkrona P; Nord M; Halldin C; Farde L; Kanes S Cephalalgia; 2013 Jul; 33(10):853-60. PubMed ID: 23430984 [TBL] [Abstract][Full Text] [Related]
16. Autoradiographic characterisation of [35S]GTPgammaS binding stimulation mediated by 5-HT1B receptor in postmortem human brain. Mostany R; Pazos A; Castro ME Neuropharmacology; 2005 Jan; 48(1):25-33. PubMed ID: 15617724 [TBL] [Abstract][Full Text] [Related]
17. (+)-WAY 100135, a partial agonist, at native and recombinant 5-HT1B/1D receptors. Davidson C; Ho M; Price GW; Jones BJ; Stamford JA Br J Pharmacol; 1997 Jun; 121(4):737-42. PubMed ID: 9208142 [TBL] [Abstract][Full Text] [Related]
18. 5-HT1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression. Verheggen R; Hundeshagen AG; Brown AM; Schindler M; Kaumann AJ Br J Pharmacol; 1998 Aug; 124(7):1345-54. PubMed ID: 9723944 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin- 1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand. Kumar JS; Majo VJ; Hsiung SC; Millak MS; Liu KP; Tamir H; Prabhakaran J; Simpson NR; Van Heertum RL; Mann JJ; Parsey RV J Med Chem; 2006 Jan; 49(1):125-34. PubMed ID: 16392798 [TBL] [Abstract][Full Text] [Related]
20. SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity. Selkirk JV; Scott C; Ho M; Burton MJ; Watson J; Gaster LM; Collin L; Jones BJ; Middlemiss DN; Price GW Br J Pharmacol; 1998 Sep; 125(1):202-8. PubMed ID: 9776361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]